The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment
- PMID: 23342380
- PMCID: PMC3528297
- DOI: 10.3390/v4123932
The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment
Abstract
We describe herein, limitations on research at biosafety level 4 (BSL-4) containment laboratories, with regard to biosecurity regulations, safety considerations, research space limitations, and physical constraints in executing experimental procedures. These limitations can severely impact the number of collaborations and size of research projects investigating microbial pathogens of biodefense concern. Acquisition, use, storage, and transfer of biological select agents and toxins (BSAT) are highly regulated due to their potential to pose a severe threat to public health and safety. All federal, state, city, and local regulations must be followed to obtain and maintain registration for the institution to conduct research involving BSAT. These include initial screening and continuous monitoring of personnel, controlled access to containment laboratories, accurate and current BSAT inventory records. Safety considerations are paramount in BSL-4 containment laboratories while considering the types of research tools, workflow and time required for conducting both in vivo and in vitro experiments in limited space. Required use of a positive-pressure encapsulating suit imposes tremendous physical limitations on the researcher. Successful mitigation of these constraints requires additional time, effort, good communication, and creative solutions. Test and evaluation of novel vaccines and therapeutics conducted under good laboratory practice (GLP) conditions for FDA approval are prioritized and frequently share the same physical space with important ongoing basic research studies. The possibilities and limitations of biomedical research involving microbial pathogens of biodefense concern in BSL-4 containment laboratories are explored in this review.
Similar articles
-
Negative impact of laws regarding biosecurity and bioterrorism on real diseases.Clin Microbiol Infect. 2014 Jun;20(6):507-15. doi: 10.1111/1469-0691.12709. Clin Microbiol Infect. 2014. PMID: 24909400 Review.
-
Implementation of a personnel reliability program as a facilitator of biosafety and biosecurity culture in BSL-3 and BSL-4 laboratories.Biosecur Bioterror. 2013 Jun;11(2):130-7. doi: 10.1089/bsp.2013.0024. Epub 2013 Jun 7. Biosecur Bioterror. 2013. PMID: 23745523 Free PMC article.
-
The hidden face of academic researches on classified highly pathogenic microorganisms.Infect Genet Evol. 2015 Jan;29:26-34. doi: 10.1016/j.meegid.2014.10.028. Epub 2014 Nov 7. Infect Genet Evol. 2015. PMID: 25445654
-
[Biosafety and biosecurity in the medical laboratory. Update and trends].Bacteriol Virusol Parazitol Epidemiol. 2007 Jul-Dec;52(3-4):91-9. Bacteriol Virusol Parazitol Epidemiol. 2007. PMID: 19326721 Review. Romanian.
-
Biosafety and biosecurity measures: management of biosafety level 3 facilities.Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S70-4. doi: 10.1016/j.ijantimicag.2010.06.026. Epub 2010 Aug 30. Int J Antimicrob Agents. 2010. PMID: 20801002 Review.
Cited by
-
ABSL-4 aerobiology biosafety and technology at the NIH/NIAID integrated research facility at Fort Detrick.Viruses. 2014 Jan 7;6(1):137-50. doi: 10.3390/v6010137. Viruses. 2014. PMID: 24402304 Free PMC article.
-
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.J Vis Exp. 2016 Oct 3;(116):53600. doi: 10.3791/53600. J Vis Exp. 2016. PMID: 27768081 Free PMC article.
-
Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.NPJ Vaccines. 2017;2:20. doi: 10.1038/s41541-017-0021-9. Epub 2017 Jul 17. NPJ Vaccines. 2017. PMID: 29167748 Free PMC article.
-
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.J Vis Exp. 2016 Oct 3;(116):52317. doi: 10.3791/52317. J Vis Exp. 2016. PMID: 27768063 Free PMC article.
-
Development and implementation of evidence-based laboratory safety management tools for a public health laboratory.Saf Sci. 2019 Aug;117:205-216. doi: 10.1016/j.ssci.2019.04.003. Saf Sci. 2019. PMID: 31156293 Free PMC article.
References
-
- CDC. Biosafety in Microbiological and Biomedical Laboratories. U. S. Department of Health and Human Services; Washington, DC, USA: 2009.
-
- NIAID. NIAID Biodefense Research Agenda for CDC Category A Agents. In Services, United States Department of Health and Human Services, National Institutes of Health; Bethesda, MD, USA: 2002.
-
- National Select Agent Registry. [(accessed on 12 December 2012)]. Available online: http://www.selectagents.gov.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical